Update shared on16 Sep 2025
Fair value Decreased 38%TeraGo's price target was cut following a substantial decline in its forward P/E ratio amid slightly weaker revenue growth expectations, lowering the fair value estimate from CA$1.60 to CA$1.00.
What's in the News
- TeraGo announced a non-brokered private placement to issue 6,547,619 common shares at CAD 0.84 for proceeds of CAD 5.5 million, with insider participation expected and subject to stock exchange approval.
- The company filed a follow-on equity offering for CAD 16.84 million, offering 20,053,411 common shares at CAD 0.84 in a rights offering.
Valuation Changes
Summary of Valuation Changes for TeraGo
- The Consensus Analyst Price Target has significantly fallen from CA$1.60 to CA$1.00.
- The Future P/E for TeraGo has significantly fallen from 15.04x to 9.53x.
- The Consensus Revenue Growth forecasts for TeraGo has fallen from 1.4% per annum to 1.3% per annum.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.